Anakinra: Review of recombinant human interleukin-I receptor antagonist in the treatment of rheumatoid arthritisFURST, Daniel E.Clinical therapeutics. 2004, Vol 26, Num 12, pp 1960-1975, issn 0149-2918, 16 p.Article

Serum Immunoglobulins and Risk of Infection: How Low Can You Go?FURST, Daniel E.Seminars in arthritis and rheumatism. 2009, Vol 39, Num 1, pp 18-29, issn 0049-0172, 12 p.Article

The Risk of Infections with Biologic Therapies for Rheumatoid ArthritisFURST, Daniel E.Seminars in arthritis and rheumatism. 2010, Vol 39, Num 5, pp 327-346, issn 0049-0172, 20 p.Article

Systemic sclerosis mortality in the United States 1979-1998KRISHNAN, Eswar; FURST, Daniel E.European journal of epidemiology. 2005, Vol 20, Num 10, pp 855-861, issn 0393-2990, 7 p.Article

Systemic sclerosis : hypothesis-driven treatment strategiesCHARLES, Christina; CLEMENTS, Philip; FURST, Daniel E et al.Lancet (British edition). 2006, Vol 367, Num 9523, pp 1683-1691, issn 0140-6736, 9 p.Article

Anti-tumor necrosis factor α therapy and heart failure: What have we learned and where do we go from here?KHANNA, Dinesh; MCMAHON, Maureen; FURST, Daniel E et al.Arthritis and rheumatism. 2004, Vol 50, Num 4, pp 1040-1050, issn 0004-3591, 11 p.Article

Rationale and strategies for reevaluating the ACR20FELSON, David T; FURST, Daniel E; BOERS, Maarten et al.Journal of rheumatology. 2007, Vol 34, Num 5, pp 1184-1187, issn 0315-162X, 4 p.Conference Paper

Safety of tumour necrosis factor-α antagonistsKHANNA, Dinesh; MCMAHON, Maureen; FURST, Daniel E et al.Drug safety. 2004, Vol 27, Num 5, pp 307-324, issn 0114-5916, 18 p.Article

Role of Hematopoietic stem cell transplantation for autoimmune diseasesSULLIVAN, Keith M; FURST, Daniel E.Journal of rheumatology. Supplement. 1997, Vol 24, Num 48, issn 0380-0903, 104 p.Conference Proceedings

Tumor necrosis factor antagonists : Different kinetics and/or mechanisms of action may explain differences in the risk for developing granulomatous infectionFURST, Daniel E; WALLIS, Robert; BRODER, Michael et al.Seminars in arthritis and rheumatism. 2006, Vol 36, Num 3, pp 159-167, issn 0049-0172, 9 p.Article

The status of stem cell transplantation for rheumatoid arthritis : A rheumatologist's viewFURST, Daniel E.Journal of rheumatology. Supplement. 2001, Vol 28, Num 64, pp 60-61, issn 0380-0903Conference Paper

Drugs for rheumatic diseaseDromgoole, Sydney H; Furst, Daniel E; Paulus, Harold E et al.1987, XVI-488 p, isbn 0-443-08011-9Book

Annual Medical Costs and Healthcare Resource Use in Patients with Systemic Sclerosis in an Insured PopulationFURST, Daniel E; FERNANDES, Ancilla W; IORGA, Serban R et al.Journal of rheumatology. 2012, Vol 39, Num 12, pp 2303-2309, issn 0315-162X, 7 p.Article

Gout and the risk of acute myocardial infarctionKRISHNAN, Eswar; BAKER, Joshua F; FURST, Daniel E et al.Arthritis and rheumatism. 2006, Vol 54, Num 8, pp 2688-2696, issn 0004-3591, 9 p.Article

Tacrolimus : In patients with rheumatoid arthritis. CommentaryCURRAN, Monique P; PERRY, Caroline M; FURST, Daniel E et al.Drugs (Basel). 2005, Vol 65, Num 7, pp 993-1003, issn 0012-6667, 11 p.Article

Update on disease-modifying antirheumatic drugs in the treatment of systemic sclerosisLIN, Antony T. H; CLEMENTS, Philip J; FURST, Daniel E et al.Rheumatic diseases clinics of North America. 2003, Vol 29, Num 2, pp viii-ix, issn 0889-857X, 30 p.Article

Epidemiology of Systemic Sclerosis in a Large US Managed Care PopulationFURST, Daniel E; FERNANDES, Ancilla W; IORGA, Serban R et al.Journal of rheumatology. 2012, Vol 39, Num 4, pp 784-786, issn 0315-162X, 3 p.Article

Does Incorporation of Aids and Devices Make a Difference in the Score of the Health Assessment Questionnaire-Disability Index? Analysis from a Scleroderma Clinical TrialKHANNA, Dinesh; CLEMENTS, Philip J; POSTLETHWAITE, Arnold E et al.Journal of rheumatology. 2008, Vol 35, Num 3, pp 466-468, issn 0315-162X, 3 p.Article

Articular involvement in systemic sclerosisAVOUAC, Jérôme; CLEMENTS, Philip J; KHANNA, Dinesh et al.Rheumatology (Oxford. Print). 2012, Vol 51, Num 8, pp 1347-1356, issn 1462-0324, 10 p.Article

Safety and Efficacy of Abatacept in Eight Rheumatoid Arthritis Patients With Chronic Hepatitis BKIM, Paul S; HO, Gerald Y; PRETE, Pamela E et al.Arthritis care and research. 2012, Vol 64, Num 8, pp 1265-1268, issn 0893-7524, 4 p.Article

MEDICAL COSTS AND HEALTH-CARE RESOURCE USE IN PATIENTS WITH INFLAMMATORY MYOPATHIES IN AN INSURED POPULATIONFURST, Daniel E; AMATO, Anthony A; IORGA, Serban R et al.Muscle & nerve. 2012, Vol 46, Num 4, pp 496-505, issn 0148-639X, 10 p.Article

Arthritis in Systemic Sclerosis: Systematic Review of the Literature and Suggestions for the Performance of Future Clinical Trials in Systemic Sclerosis ArthritisCLEMENTS, Philip J; ALLANORE, Yannick; KHANNA, Dinesh et al.Seminars in arthritis and rheumatism. 2012, Vol 41, Num 6, pp 801-814, issn 0049-0172, 14 p.Article

EPIDEMIOLOGY OF ADULT IDIOPATHIC INFLAMMATORY MYOPATHIES IN A U.S. MANAGED CARE PLANFURST, Daniel E; AMATO, Anthony A; IORGA, Serban R et al.Muscle & nerve. 2012, Vol 45, Num 5, pp 676-683, issn 0148-639X, 8 p.Article

Work Productivity in Scleroderma: Analysis From the University of California, Los Angeles Scleroderma Quality of Life StudySINGH, Manjit K; CLEMENTS, Philip J; FURST, Daniel E et al.Arthritis care and research. 2012, Vol 64, Num 2, pp 176-183, issn 0893-7524, 8 p.Article

Ruminating on rheumatoid arthritis and transplantationBURT, Richard K; FURST, Daniel E; WEISMAN, Michael H et al.Clinical immunology (Orlando, Fla. Print). 2005, Vol 115, Num 2, pp 129-130, issn 1521-6616, 2 p.Article